CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER: Clinical Relevance of Residual Fatigue
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Residual symptoms of major depressive disorder (MDD) following treatment are increasingly recognized as having a negative impact on the patient because of their association with lack of remission, poorer psychosocial functioning, and a more chronic course of depression. Although the effects of specific residual symptoms have not been as systematically studied, several symptoms, including fatigue, sleep disturbance, anxiety, and concentration difficulties, commonly occur as part of the residual state in MDD. In particular, the relatively high prevalence of residual fatigue suggests that this symptom is not being adequately addressed by standard antidepressant therapies. A review of the clinical relevance of residual fatigue was undertaken, using the published literature with respect to its assessment, neurobiology, and treatment implications. The findings of this review suggest that fatigue is highly prevalent as a residual symptom; its response to treatment is relatively poor or delayed; and the presence of residual fatigue is highly predictive of inability to achieve remission with treatment as well as impaired psychosocial functioning. Recognition of the significant consequences of residual fatigue should reinforce the need for further therapeutic interventions to help reduce the impact of this symptom of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 1×
“(QIDS-16 SR)[53] or assess the emergence of adverse event and tolerability, such as the Frequency, Intensity, and Burden of Side Effect Rating (FIBSER).”
BackgroundSelf-citationDevelopment of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 1×
“In another study, the psychometric properties of the Fatigue Questionnaire (FQ)[25] were examined in 81 patients with MDD who, again, did not have comorbid medical conditions related to fatigue.”
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 1×
“25%).[5] In a 10-year prospective study, 237 patients with MDD were classified at study baseline as either having residual symptoms (n = 82) or being asymptomatic (n = 155); patients with residual symptoms experienced their next depressive episode three to five times faster than patients who were asymptomatic.”
BackgroundDistinguishing sleepiness and fatigue: focus on definition and measurement
Shen, J., Barbera, J., & Shapiro, C. M. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.05.004 · Cited by 687
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Conradi, H. J., Ormel, J., & de Jonge, P. (2011) · Psychological Medicine · doi:10.1017/s0033291710001911 · Cited by 515
Residual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470 · cited 1×
“3% Residual fatigue for patients who meet remission criteria Clinical trial[32] Fluoxetine 108 SCID fatigue item 38% Elderly STAGED study[30] SSRI, TCAs 86 MADRS lassitude item 41.”
BackgroundSelf-citation
Cited by
Salamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Lam, R. W., McIntosh, D., Wang, J., Enns, M. W., Kolivakis, T., Michalak, E. E., Sareen, J., Song, W.-Y., Kennedy, S. H., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659416 · Cited by 288
Mesolimbic Dopamine and the Regulation of Motivated Behavior
Salamone, J. D., Pardo, M., Yohn, S. E., López-Cruz, L., SanMiguel, N., & Correa, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_383 · Cited by 204
Dopamine, effort-based choice, and behavioral economics: basic and translational research.
Salamone, J. D., Correa, M., Yang, J.-H., Rotolo, R., & Presby, R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00052 · Cited by 142
Ghanean, H., Ceniti, A. K., & Kennedy, S. H. (2018) · CNS Drugs · doi:10.1007/s40263-018-0490-z · Cited by 108
Hird, E. J., Slanina-Davies, A., Lewis, G., Hamer, M., & Roiser, J. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02922-y · Cited by 79
“Antidepressants are generally ineffective for treating motivational dysfunction and can even exacerbate these symptoms in some patients, indicating an important unmet clinical need [66 – 68].”
BackgroundFerré, S., Díaz-Ríos, M., Salamone, J. D., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0017 · Cited by 52
Østergaard, T., Lundgren, T., Zettle, R. D., Landrø, N. I., & Haaland, V. Ø. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00528 · Cited by 45
How Postpartum Women With Depressive Symptoms Manage Sleep Disruption and Fatigue
Doering, J. J., Sims, D. A., & Miller, D. D. (2017) · Research in Nursing & Health · doi:10.1002/nur.21782 · Cited by 22
Clinical Phenotype of Depression Affects Interleukin-6 Synthesis
Zadka, Ł., Dzięgiel, P., Kulus, M., & Olajossy, M. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0074 · Cited by 20
Eggart, M., Valdés-Stauber, J., Müller-Oerlinghausen, B., & Heinze, M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05168-y · Cited by 13
“The prevention and treat-ment of residual symptoms of fatigue is not adequately addressed in available guidelines, although their clinical and psychosocial impact is increasingly recognized [4, 5].”
BackgroundInfluential
Metadata
- Authors
- Fava, M., Ball, S., Nelson, J. C., Sparks, J., Konechnik, T., Classi, P., Dube, S., & Thase, M. E.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2013-10-01
- Volume
- 31
- Issue
- 3
- Pages
- 250-257
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W1484576876
- Cited by
- 160
- References
- 17
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.